| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/26/2003 | EP1364214A1 Reagent for ante-mortem screening of ntac |
| 11/26/2003 | EP1364213A2 Screening under isothermal denaturing conditions |
| 11/26/2003 | EP1364212A2 Three hybrid assay system |
| 11/26/2003 | EP1364211A1 Method for detecting macromolecular biopolymers by using at least one immobilizing unit provided with a marked scavenger molecule |
| 11/26/2003 | EP1364210A2 Method and apparatus for selective biological material detection |
| 11/26/2003 | EP1364209A2 Activity based probe analysis |
| 11/26/2003 | EP1364208A2 Conjugates of defined stoichiometry |
| 11/26/2003 | EP1364207A2 Rapid methods for microbial typing and enumeration |
| 11/26/2003 | EP1364206A2 Rapid method for screening compounds for in vivo activity |
| 11/26/2003 | EP1364204A1 Designs of labels for detection with a surface-selective nonlinear optical technique |
| 11/26/2003 | EP1364201A1 Ligand sensor devices and uses thereof |
| 11/26/2003 | EP1364197A2 High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation |
| 11/26/2003 | EP1364070A2 Optoelectronic detection system |
| 11/26/2003 | EP1364069A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 11/26/2003 | EP1364067A2 Prc17: an amplified cancer gene |
| 11/26/2003 | EP1364066A2 Method for identifying functional nucleic acids |
| 11/26/2003 | EP1364065A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 11/26/2003 | EP1364062A2 Diagnostic test for the detection of chromosomal abnormalities in a fetus |
| 11/26/2003 | EP1364058A2 Method for maldi-tof-ms analysis and/or sequencing of oligonucleotides |
| 11/26/2003 | EP1364057A2 Ligand detection method |
| 11/26/2003 | EP1364056A2 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits |
| 11/26/2003 | EP1364055A2 Solubility reporter gene constructs |
| 11/26/2003 | EP1364054A2 Method of determining a chemotherapeutic regimen based on ercc1 expression |
| 11/26/2003 | EP1364053A2 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 11/26/2003 | EP1364052A2 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 11/26/2003 | EP1364051A2 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure |
| 11/26/2003 | EP1364048A2 Method of performing subtractive hybridization |
| 11/26/2003 | EP1364046A2 Methods for genetic analysis of dna to detect sequence variances |
| 11/26/2003 | EP1364044A2 Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine |
| 11/26/2003 | EP1364043A1 Methods and kits for identifying scavengers of reactive oxygen species (ros) |
| 11/26/2003 | EP1364042A1 Method for determining concentration of an analyte in a test strip |
| 11/26/2003 | EP1364031A1 Hiv-like particles and the use thereof |
| 11/26/2003 | EP1364026A2 Human g protein-coupled receptor |
| 11/26/2003 | EP1364021A2 Compositions and methods relating to colon specific genes and proteins |
| 11/26/2003 | EP1364019A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 11/26/2003 | EP1364018A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 11/26/2003 | EP1364014A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses |
| 11/26/2003 | EP1364009A2 Regulatable, catalytically active nucleic acids |
| 11/26/2003 | EP1363998A1 Novel human poly(a)polymerase gamma (pap gamma) |
| 11/26/2003 | EP1363996A2 Epothilone resistant cell lines |
| 11/26/2003 | EP1363954A2 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 11/26/2003 | EP1363950A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors |
| 11/26/2003 | EP1363949A1 Functional fragment of the leptine receptor |
| 11/26/2003 | EP1363948A1 Polypeptide of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids coding therefor and use thereof |
| 11/26/2003 | EP1363946A2 Methods of dissociating nongenotropic from genotropic activity of steroid receptors |
| 11/26/2003 | EP1363942A2 Polypeptide from a hdm2 protein specific murine alpha/beta t-cell receptors, nucleic acids coding for the above and use thereof |
| 11/26/2003 | EP1363941A2 Histidine phosphatase interacting protein of 120 kd |
| 11/26/2003 | EP1363940A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 11/26/2003 | EP1363936A1 Juvenile hormone esterase |
| 11/26/2003 | EP1363935A2 Ter sites and ter binding proteins |
| 11/26/2003 | EP1363929A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 11/26/2003 | EP1363920A1 Modified psma ligands and uses related thereto |
| 11/26/2003 | EP1363736A2 Automated laboratory system and method |
| 11/26/2003 | EP1363714A1 A microchip electrospray device and column with affinity adsorbents and use of the same |
| 11/26/2003 | EP1363665A2 Vaccine |
| 11/26/2003 | EP1363662A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo ; analysis of vaccinating composition in vitro |
| 11/26/2003 | EP1363655A2 Isolated nucleic acid molecules encoding a human and mouse g protein-coupled receptor - gpr54; encoded proteins, cells transformed therewith and uses thereof |
| 11/26/2003 | EP1363654A2 Fab i and inhibition of apicomplexan parasites |
| 11/26/2003 | EP1363643A2 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 11/26/2003 | EP1363625A1 Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders |
| 11/26/2003 | EP1363529A2 Rare event detection system |
| 11/26/2003 | EP1363528A2 Methods for diagnosing and treating heart disease |
| 11/26/2003 | EP1224471B1 Dpi-6, a therapeutic biomarker in neurological disorders |
| 11/26/2003 | EP1102561B1 Press device for a gel/sensor assembly |
| 11/26/2003 | EP1055124B1 Method and composition for inhibition of nitric oxide production in the oral cavity |
| 11/26/2003 | EP1051608B1 Optical sensor and method of operation |
| 11/26/2003 | EP0953056B1 Nucleic acid sequencing with solid phase capturable terminators |
| 11/26/2003 | EP0871492B1 Mesothelium antigen and methods and kits for targeting it |
| 11/26/2003 | EP0859627B1 Mimicking peptides in cancer therapy |
| 11/26/2003 | EP0822861B1 Remotely programmable matrices with memories and uses thereof |
| 11/26/2003 | EP0759693B1 METHODS FOR THE IDENTIFICATION OF COMPOUNDS CAPABLE OF ABROGATING HIV-1 Vpr-rip-1 BINDING INTERACTIONS |
| 11/26/2003 | EP0635054B1 Mammalian melanocyte stimulating hormone receptors and uses |
| 11/26/2003 | CN2588361Y Micro-quantity liquid blowing and sucking device |
| 11/26/2003 | CN2587550Y Instrument for detecting spheroidization rate of casting piece |
| 11/26/2003 | CN1459025A Quality testing method and prodution method of rare earth magnet alloy ingot, the rare earth magnet alloy ingot, and rare earth magnet alloy |
| 11/26/2003 | CN1458980A Assay for soluble fibrin |
| 11/26/2003 | CN1458979A Modulating multiple lineage kinase proteins |
| 11/26/2003 | CN1458978A Enzyme activated chemotherapy of liver cancer |
| 11/26/2003 | CN1458973A Pre-adipose cell lines |
| 11/26/2003 | CN1458972A Device for measuring extracellular potential, method of measuring extracellular potential by using the same, and apparatus for quick screening drugs provided therewith |
| 11/26/2003 | CN1458936A HIV peptides from Tat, Rev and Nef conserved regions and their application as E.G. vaccine components |
| 11/26/2003 | CN1458925A Lipo-or amphlic scintillators and their use in assays |
| 11/26/2003 | CN1458866A Device for heat-dependent chain amplication of target nucleic acid sequences |
| 11/26/2003 | CN1458527A Immune chromatographic paper strip and method for quick detecting pathogen and toxin in food |
| 11/26/2003 | CN1458526A Test sheet with multiple reaction area and method for using and producing said test sheet |
| 11/26/2003 | CN1458525A Integrated capillary biological chip and its producing method |
| 11/26/2003 | CN1458523A New technological method-2 for detecting shear wave speed in geotechnical static and dynamic triaxial instrument |
| 11/26/2003 | CN1458522A New technological method-1 for detecting shear wave speed in geotechnical static and dynamic triaxial instrument |
| 11/26/2003 | CN1458285A Multifunctional polymerized film and its device |
| 11/26/2003 | CN1458280A Two artificial synthetic PRRS virus multiple opitope tandem pucleotide sequences and their use |
| 11/26/2003 | CN1458168A Recombined pig influenza virus NP antigen, its preparing method and use in diagnosis |
| 11/26/2003 | CN1458167A Truncated express pig gyrate virus Ôàí type capsid protein antigen and its use |
| 11/26/2003 | CN1458165A Poly peptide matter and its preparing method and use |
| 11/26/2003 | CN1458163A Oriental waterplantain rhizome sterol extract and its preparing method and quality control method |
| 11/26/2003 | CN1129005C Device and its method for measuring crude petroleum water content |
| 11/26/2003 | CN1129004C Glutaraldehyde content determining method for medical apparatus and instrument disinfecting liquid |
| 11/26/2003 | CN1129002C Method for producing enzyme-electrode test strip of electrochemical sensor for testing blood sugar by using vitrification technique |
| 11/26/2003 | CN1128884C Methods and compositions for efficient nucleic acid sequencing |
| 11/26/2003 | CN1128876C Transferrin receptor genes of moraxella |
| 11/25/2003 | US6654696 Method for nucleic acid sequence determination using codes for error correction |